Q16288 (NTRK3_HUMAN) Homo sapiens (Human)
NT-3 growth factor receptor UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
5 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of TRKc in complex with 3-((6-(4-aminophenyl)imidazo[1,2-a]pyrazin-3-yl)ethynyl)-… | monomer | 100.0 | 1×DZ6; 1×PO4; | |||
| crystal structure of TRKc in complex with 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methyl-N-(3-((4- … | monomer | 100.0 | 1×DZC; | |||
| Discovery of a selective TRK Inhibitor with efficacy in rodent cancer tumor models | monomer | 100.0 | 1×CL; 1×0F4; | |||
| (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK … | monomer | 100.0 | 1×4EJ; 3×GOL; 1×CL; | |||
| NT3 BINDING DOMAIN OF HUMAN TRKC RECEPTOR | monomer | 100 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5kmj.1.A | monomer | 0.73 | 76.22 | |||
| 7n3t.1.A | monomer | 0.62 | 38.24 | |||
10 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 7n3t.1.A | monomer | 0.62 | 38.42 | |||
| Isoform 2 | 3zyo.1.A | monomer | 0.56 | 27.41 | |||
| Isoform 2 | 3dmk.1.B | monomer | 0.56 | 22.33 | |||
| Isoform 2 | 3b43.1.A | monomer | 0.54 | 22.64 | |||
| Isoform 3 | 5kmj.1.A | monomer | 0.77 | 76.22 | |||
| Isoform 3 | 7n3t.1.A | monomer | 0.60 | 38.24 | |||
| Isoform 4 | 5kmj.1.A | monomer | 0.73 | 76.22 | |||
| Isoform 4 | 7n3t.1.A | monomer | 0.61 | 38.42 | |||
| Isoform 5 | 5kmj.1.A | monomer | 0.77 | 76.22 | |||
| Isoform 5 | 7n3t.1.A | monomer | 0.61 | 38.42 | |||